Back to Search
Start Over
Evaluation of different doses of dexmedetomidine for awake fibreoptic nasotracheal intubation in patients undergoing oromaxillofacial and oral malignancy surgeries: A randomised, double-blind study
- Source :
- Indian Journal of Anaesthesia, Vol 68, Iss 5, Pp 447-453 (2024)
- Publication Year :
- 2024
- Publisher :
- Wolters Kluwer Medknow Publications, 2024.
-
Abstract
- Background and Aims: In patients undergoing cancer surgeries with anticipated difficult airway, awake fibreoptic nasotracheal intubation (AFONI) is critical for securing the airway. However, different doses of dexmedetomidine (DEX) are yet to be evaluated in these patients. Thus, we compared three doses of DEX for AFONI in patients undergoing oromaxillofacial and oral malignancy surgeries. Methods: In this randomised, double-blind study, 90 patients aged 18–60 years of either gender, with American Society of Anesthesiologists physical status I/II, and undergoing elective oromaxillofacial and oral malignancy surgeries were randomised to three groups: Group D1 (0.5 μg/kg DEX), Group D2 (1 μg/kg DEX), and Group D3 (1.5 μg/kg DEX). The primary outcome measure was the airway obstruction score. Secondary outcome measures were intubation scores (including vocal movement, coughing, and limb movements) and a 5-point fibreoptic intubation comfort score. Sedation was assessed using the Ramsay sedation score (RSS). One-way ANOVA and Chi-square test were used to assess the association between quantitative and qualitative variables, respectively. A P value of
Details
- Language :
- English
- ISSN :
- 00195049 and 09762817
- Volume :
- 68
- Issue :
- 5
- Database :
- Directory of Open Access Journals
- Journal :
- Indian Journal of Anaesthesia
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.444aee228d764a9695506795a6d049e3
- Document Type :
- article
- Full Text :
- https://doi.org/10.4103/ija.ija_1004_23